Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

H3K9 acetylation and radial chromatin positioning

L. Strašák, E. Bártová, A. Harničarová, G. Galiová, J. Krejčí, S. Kozubek

. 2009 ; 220 (1) : 91-101.

Jazyk angličtina Země Spojené státy americké

Perzistentní odkaz   https://www.medvik.cz/link/bmc11009401

Histone variants and their epigenetic modifications determine genome function, particularly transcription. However, whether regulation of gene expression can be influenced by nuclear organization or vice versa is not completely clear. Here, we analyzed the effect of epigenetic changes induced by a histone deacetylase inhibitor (HDACi) on the nuclear radial rearrangement of select genomic regions and chromosomes. The HDACi, sodium butyrate (NaBt), induced differentiation of human adenocarcinoma HT29 cells as well as a genome-wide increase in H3K9 acetylation. Three-dimensional analysis of nuclear radial distributions revealed that this increase in H3K9 acetylation was often associated with a repositioning of select loci and chromosomes toward the nuclear center. On the other hand, many centromeres resided sites more toward the nuclear periphery, similar to sites occupied by chromosome X. In more than two-thirds of events analyzed, central nuclear positioning correlated with a high level of H3K9 acetylation, while more peripheral positioning within interphase nuclei correlated with a lower level of acetylation. This was observed for the gene-rich chromosomes 17 and 19, TP53, and CCND1 genes as well as for gene-poor chromosome 18, APC gene, regions of low transcriptional activity (anti-RIDGEs), and the relatively transcriptionally less active chromosome X. These results are consistent with a role for epigenetic histone modifications in governing the nuclear radial positioning of genomic regions during differentiation.

Citace poskytuje Crossref.org

000      
04243naa 2200685 a 4500
001      
bmc11009401
003      
CZ-PrNML
005      
20121112124424.0
008      
110510s2009 xxu e eng||
009      
AR
024    __
$a 10.1002/jcp.21734 $2 doi
035    __
$a (PubMed)19248079
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Strašák, Luděk $7 xx0143300
245    10
$a H3K9 acetylation and radial chromatin positioning / $c L. Strašák, E. Bártová, A. Harničarová, G. Galiová, J. Krejčí, S. Kozubek
314    __
$a Department of Molecular Cytology and Cytometry, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic.
520    9_
$a Histone variants and their epigenetic modifications determine genome function, particularly transcription. However, whether regulation of gene expression can be influenced by nuclear organization or vice versa is not completely clear. Here, we analyzed the effect of epigenetic changes induced by a histone deacetylase inhibitor (HDACi) on the nuclear radial rearrangement of select genomic regions and chromosomes. The HDACi, sodium butyrate (NaBt), induced differentiation of human adenocarcinoma HT29 cells as well as a genome-wide increase in H3K9 acetylation. Three-dimensional analysis of nuclear radial distributions revealed that this increase in H3K9 acetylation was often associated with a repositioning of select loci and chromosomes toward the nuclear center. On the other hand, many centromeres resided sites more toward the nuclear periphery, similar to sites occupied by chromosome X. In more than two-thirds of events analyzed, central nuclear positioning correlated with a high level of H3K9 acetylation, while more peripheral positioning within interphase nuclei correlated with a lower level of acetylation. This was observed for the gene-rich chromosomes 17 and 19, TP53, and CCND1 genes as well as for gene-poor chromosome 18, APC gene, regions of low transcriptional activity (anti-RIDGEs), and the relatively transcriptionally less active chromosome X. These results are consistent with a role for epigenetic histone modifications in governing the nuclear radial positioning of genomic regions during differentiation.
590    __
$a bohemika - dle Pubmed
650    _2
$a acetylace $7 D000107
650    _2
$a adenokarcinom $x enzymologie $x genetika $7 D000230
650    _2
$a butyráty $x farmakologie $7 D002087
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a buněčné jádro $x enzymologie $x patologie $x účinky léků $7 D002467
650    _2
$a proliferace buněk $7 D049109
650    _2
$a restrukturace chromatinu $x účinky léků $7 D042002
650    _2
$a lidské chromozomy $x metabolismus $7 D002877
650    _2
$a lidské chromozomy, pár 17 $x metabolismus $7 D002886
650    _2
$a lidské chromozomy, pár 18 $x metabolismus $7 D002887
650    _2
$a lidské chromozomy, pár 19 $x metabolismus $7 D002888
650    _2
$a nádory tračníku $x enzymologie $x genetika $7 D003110
650    _2
$a cyklin D1 $x genetika $7 D019938
650    _2
$a enterocyty $x účinky léků $7 D020895
650    _2
$a enterocyty $x enzymologie $x patologie $7 D020895
650    _2
$a inhibitory enzymů $x farmakologie $7 D004791
650    _2
$a epigeneze genetická $x účinky léků $7 D044127
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a geny APC $7 D017491
650    _2
$a buňky HT-29 $7 D019073
650    _2
$a inhibitory histondeacetylas $7 D056572
650    _2
$a histondeacetylasy $7 D006655
650    _2
$a histony $x metabolismus $7 D006657
650    _2
$a lidé $7 D006801
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a posttranslační úpravy proteinů $x účinky léků $7 D011499
650    _2
$a nádorový supresorový protein p53 $x genetika $7 D016159
650    _2
$a financování organizované $7 D005381
700    1_
$a Bártová, Eva. $7 xx0028314
700    1_
$a Harničarová, Andrea. $7 mub2011654526
700    1_
$a Šustáčková, Gabriela. $7 mub2012692379
700    1_
$a Krejčí, Jana $7 xx0128638
700    1_
$a Kozubek, Stanislav, $d 1953- $7 ola2003204933
773    0_
$t Journal of Cellular Physiology $w Journal of cellular physiology $g Roč. 220, č. 1 (2009), s. 91-101
910    __
$a ABA008 $b x $y 2
990    __
$a 20110513104945 $b ABA008
991    __
$a 20121112124438 $b ABA008
999    __
$a ok $b bmc $g 838979 $s 702786
BAS    __
$a 3
BMC    __
$a 2009 $x MED00009981 $b 220 $c 1 $d 91-101 $m Journal of cellular physiology $n J Cell Physiol
LZP    __
$a 2011-2B09/jvme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé